GlaxoSmithKline produced clinical data on Wednesday showing its newly approved three-in-one inhaler reduced life-threatening attacks in chronic... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/gUghUm300Ro/gsks-new-triple-lung-drug-beats-other-modern-inhalers-in-study-idINKCN1BV0WW
By David Shepardson WASHINGTON (Reuters) - A federal magistrate judge blocked the U.S. Justice Department from sharing with a German law firm 25... ...http://www.sify.com/news/justice-department-barred-from-sharing-vw-documents-judge-news-crime-rjsxv0gfcbaaa.html
French biotech company Neovacs is confident that its experimental drug to treat lupus could grab significant market share from standard treatments... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/yRs1cZzKdO0/frances-neovacs-takes-on-gsk-and-astrazeneca-in-battle-to-treat-lupus-idINKCN1BQ1Z1
A U.S. Food and Drug Administration advisory panel on Wednesday voted 11-0 that the safety and efficacy of GlaxoSmithKline’s Shingrix... ...http://feeds.reuters.com/~r/reuters/INhealth/~3/1Z2OrjJHH9c/impressed-fda-panel-unanimously-recommends-gsk-shingles-vaccine-idINKCN1BO2GB
With global pharmaceutical giant Pfizer getting a patent last month for its pneumonia vaccine, Indian companies' plans to introduce cheaper... ...http://www.business-standard.com/article/opinion/patent-to-pfizer-could-delay-indian-vaccines-for-pneumonia-117091101548_1.html
Advair Diskus 500/50mcg is a...